Diabetes

Researchers in Taiwan have found an increase in the risk for head and neck cancers among patients with diabetes mellitus (DM) equivalent to approximately 2.6 additional cases per 10,000 person-years in patients with DM versus patients without DM.

Diabetes control worsened for patients with diabetes who received or were receiving androgen deprivation therapy for prostate cancer.

Jonathan G. Marquess, PharmD, CDE, President and CEO of the Institute for Wellness and Education, Inc, discusses how all pharmacies can manage diabetes patients.

Starlin Haydon-Greatting, MS, BSPharm, FAPHA, discusses the training pharmacists should pursue if they are interested in playing a role in patient-centered diabetes care.

Pharmacists can learn about current management of type 2 diabetes mellitus, including updated clinical practice guidelines and the incorporation of new therapeutic classes into practice recommendations.

Pharmacists can make a difference through screening, counseling, and treatment.

An analysis of 2 randomized trials of statin therapy for patients enrolled after an acute coronary syndrome finds that high-dose statins do not increase the risk of kidney injury.

The prevalence of type 2 diabetes increased 30.5%, and the prevalence of type 1 diabetes increased 21.1% in US youth between 2001 and 2009, a study finds.

According to a recent study, one-fifth of those aged 60 or older who were candidates for pharmacologic therapy under JNC 7 would rely on lifestyle blood pressure control under JNC 8.

Starlin Haydon-Greatting, MS, BSPharm, FAPHA, discusses the range of education and training that prepares pharmacists to play a role in patient-centered diabetes care.

Teams consisting of a clinical pharmacist, a pharmacy resident, and a pharmacy technician have helped patients get blood pressure and blood sugar under control, corrected medication errors, and reduced hospitalization rates.

Our round-up of new Rx products.

Pharmacists can emphasize to patients that anxiety is a real disease with effective treatments.

A 50-year-old male with a history of benign prostatic hyperplasia, chronic obstructive pulmonary disease, and type 2 diabetes mellitus is admitted for a laparoscopic colectomy. The patient's surgeon requests a pharmacy consultation to develop a multimodal, opioid-sparing pain control regimen.